Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: A pilot study

European Annals of Allergy and Clinical Immunology

Volumn 37, Issue 1, 2005, Pages 25-29

  Ciprandi, G ^a   Cirillo, I G ^b   Vizzaccaro, A ^b   Tosca, M A ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b Ospedale Marina Militare   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

Decongestion test; Levocetirizine; Nasal airflow; Nasal obstruction; Persistent allergic rhinitis; Rhinomanometry

Indexed keywords

ANTIHISTAMINIC AGENT; DECONGESTIVE AGENT; LEVOCETIRIZINE; PLACEBO;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; NOSE AIRFLOW; NOSE IRRITATION; NOSE OBSTRUCTION; PHYSICAL EXAMINATION; PILOT STUDY; PRICK TEST; RANDOMIZED CONTROLLED TRIAL; RHINOMANOMETRY; RHINORRHEA; SIDE EFFECT; SNEEZING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CETIRIZINE; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MALE; NAPHAZOLINE; NASAL OBSTRUCTION; PILOT PROJECTS; PIPERAZINES; PRURITUS; RHINITIS, ALLERGIC, PERENNIAL; RHINOMANOMETRY; SKIN TESTS;

EID: 13544257240     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bellanti J.-A., Wallerstedt D.-B. - Allergic rhinitis update: epidemiology and natural history. Allergy Asthma Proc 2000;21:367-70.
2. Nathan R.-A., Meltzer E.-O., Seiner J.-C., Storms W. - The prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:22-7.
3. Cirillo I., Vizzaccaro A., Tosca M.-A., Milanese M., Ciprandi G. - Prevalence and treatment of allergic rhinitis in Italian conscript. Eur Ann Allergy Clin Immunol 2003;35:204-7.
4. Christodoupoulos P., Cameron L., Durham S., Hamid Q. - Molecular pathology of allergic disease II: upper airway disease J Allergy Clin Immunol 2000;105:211-223.
5. Horak F. - Impact and modulation of nasal obstruction. Allergy 2002;57(suppl. 75):25-8.
6. Bousquet J. - Requirements for medication commonly used in the treatment of allergic rhinitis. Allergy 2003;58: 192-7.
7. Gentile D.-A., Friday G.-A., Skoner D.-P. - Management of allergic rhinitis: antihistamines and decongestants. Immunol Clin North Am 2000;20:355-68.
8. Bachert C., Brostoff J., Scadding G.-K. and al. - Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis Allergy 1998;53:969-75.
9. Lipworth B.-J., Wilson A.-M., Haggart K., Sims E.-J. - Differences in in-vitro H1-receptor antagonist potency with fexofenadine and desloratadine do not determine effects on nasal congestion in seasonal allergic rhinitis. Allergy 2002;57(suppl 73):10.
10. Horak F., Stubner U.-P., Ziegelmayer R., Harris A.-G. - Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J Allergy Clin Immunol 2002;109:956-61.
11. Ciprandi G., Cosentino C., Milanese M. and al. - Fexofenadine treatment reduces nasal congestion in allergic rhinitis Allergy 2001;56:1068-1070.
12. Church M.-K. - H1-antihistamines and inflammation Clin Exp Allergy 2001;31:1341-3.
13. Devalia J.-L., De Vos C., Hanotte F., Baltes E. - A randomized double-blind crossover comparison among cetirizine, levocetirizine and UCB 28557 on histamine-induced cutaneous responses in healthy adult volunteers. Allergy 2001;56:50-7.
14. Wang D.-Y., Hanotte F., De Vos C., Clement P. - Effect of cetirizine, levocetirizine and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers. Allergy 2001;56:339-43.
15. Thomson L., Blaylock M.-G., Sexton D.-W. and al. - Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy 2002;32:1187-92.
16. Lee D.-K., Bates C.-E., Currie G.-P., Lipworth B.-J. - Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma. J Allergy Clin Immunol 2003;111:337-41.
17. Potter P.-C. - Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy 2003;58:893-9.
18. Bousquet J., Van Cauwenberge P., Khaltaev N. - Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl):S147-S334.
19. Società Italiana di Allergologia e Immunologia Clinica: "Memorandum della Diagnostica delle Allergopatie". Fed Med 1987;40:861-874.
20. Corey J.-P., Houser S.-M., Ng B.-A. - Nasal congestion: a review of its etiology, evaluation, and treatment ENT J 2000;79:690-701.
21. Tsicopoulos A., de Nadai P. - Antihistamines as antiinflammatory agents. Clin Exp Allergy 2003;33:1476-8.
22. Spector S. - Ideal pharmacotherapy for allergic rhinitis. J Allergy Clin Immunol 1999;103(Suppl.):386-7.
23. Ciprandi G., Cirillo I., Vizzaccaro A., Tosca M.-A. - Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study. Clin Exp Allergy 2004;34:958-64.